Clearside Biomedical, Inc. (CLSD) - Company Sales

Corporate emblem and logo of Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical generates revenue by licensing unique eye microinjection technologies while minimizing production costs. Environmental responsibility in waste disposal and packaging is evidenced through the company's operating sales, where the metric stood at 0.00. This trend confirms the issuer's financial stability, while current royalties from XIPERE provide a capital inflow in anticipation of new deals.

CLSD - Clearside Biomedical, Inc. Revenue and Sales Volume over the range 07/04/2022 - 12/13/2025

Analytical breakdowns for Clearside Biomedical

- market value and analyst target forecast:
Market Chart Clearside Corp|CLSD - Analyst Consensus Forecast
- market capitalization indicators:
Market Valuation Clearside Biomedical, Inc.|CLSD - Total Company Value
- balance sheet equity data:
Net Assets per Single Share Clearside Biomedical|CLSD - Book Capitalization|Market-to-Book Ratio clearsidebio.com|CLSD - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Clearside Biomedical|CLSD - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Clearside Biomedical Inc|CLSD - Company Debts|Debts to Net Assets Clearside Biomedical, Inc.|CLSD - Company Long-Term Debts|Short-Term Debt Volume Clearside Biomedical|Immediate Liquidity Ratio clearsidebio.com
- earnings and market ratios statistics:
CLSD - Net Profit|Expected Net Profit Clearside Biomedical|CLSD - Price to Earnings Ratio|Future Price to Earnings Multiple clearsidebio.com|CLSD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Clearside Biomedical, Inc.|CLSD - Operating profit EBITDA|Net earnings per share for the last four quarters Clearside Biomedical|CLSD - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months clearsidebio.com|CLSD - Earnings per share growth in current year|Expected earnings per share growth for next year Clearside Biomedical
- company sales and revenue statistics:
CLSD - Revenue and Sales Volume|Company Expected Sales Volume Clearside Corp|CLSD - P/S Multiple|Market Cap to Projected Revenue Clearside Biomedical, Inc.
Comprehensive company analysis:Clearside Biomedical
Core merchandise of Clearside Biomedical Inc

This indicator is critically important when stress-testing assets to assess cash flow resilience. The metric measures the net volume of daily inflows, allowing for the identification of operational disruptions and real demand dynamics. By analyzing the sales trend of the company, an investor can see the efficiency of the products' commercial realization. For Clearside Biomedical (CLSD), this reflects the impact of implementing robotic systems and data validation automation on total revenue.

Key competitors

Alcon Corp (ALC) - Company Gross Revenue|Revenue and Sales Volume BLCO|Company Sales glaukos.com GKOS|Company Revenue Apellis APLS|Belite Bio Corp - Company Revenue|Ocular Therapeutix Corp - Revenue and Sales Volume|Company Total Revenue Harrow Corp|VRDN: Revenue and Sales Volume|lenz-tx.com (LENZ) - Revenue and Sales Volume|Company Revenue Oculis Holding AG|EYPT: Company Sales Revenue|Company Revenue Kodiak Pharma (KOD)|Company Gross Revenue aldeyra.com|Revenue and Sales Volume KALA (KALA BIO)|Company Gross Revenue Opus Genetics, Inc. (IRD)|OKYO Pharma Inc - Revenue and Sales Volume|ADVM (Adverum Biotechnologies) - Company Sales Volume|OTLK: Revenue and Sales Volume|Company Total Revenue NovaBay Pharmaceuticals, Inc. (NBY)|Company Sales KPRX|ALIM: Company Sales Revenue|Revenue and Sales Volume EYEN|Company Revenue GHSI (Guardion Health Sciences, Inc.)|Revenue and Sales Volume OCUP (Ocuphire)|Company Gross Revenue Opthea Corp (OPT)